S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Amphastar Pharmaceuticals (AMPH) SEC Filings & 10K Form

$40.78
+1.16 (+2.93%)
(As of 04/15/2024 ET)

Recent Amphastar Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/02/2024
8:31 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:47 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:49 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:52 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:32 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:54 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:57 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:29 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:49 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:51 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
9:23 AM
Amphastar Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
03/05/2024
12:21 PM
Amphastar Pharmaceuticals (Subject)
ZASLOFF MICHAEL A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:35 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:53 PM
Amphastar Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
3:38 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
4:21 PM
Amphastar Pharmaceuticals (Subject)
Zhang Jack Y. (Filed by)
Form SC 13G/A
02/02/2024
6:37 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
10:53 AM
Amphastar Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/17/2024
1:36 PM
Amphastar Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
01/11/2024
3:37 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
5:27 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:25 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:22 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:23 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2024
6:25 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:25 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:49 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:11 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
4:23 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:34 AM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2023
3:30 PM
Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
3:31 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
11:38 AM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
11:38 AM
Amphastar Pharmaceuticals (Subject)
Deflin Gayle (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
7:37 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
5:38 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.
10/02/2023
3:01 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:11 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2023
5:54 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
7:22 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
7:23 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
4:24 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K/A
08/15/2023
1:14 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
11:54 AM
Amphastar Pharmaceuticals (Subject)
ZASLOFF MICHAEL A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
3:21 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
4:05 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:05 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:36 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
7:12 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
7:13 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
5:24 PM
Amphastar Pharmaceuticals (Issuer)
Gerst Diane G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
4:18 PM
Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
4:19 PM
Amphastar Pharmaceuticals (Issuer)
Lee Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
4:20 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
5:49 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
11:27 AM
Amphastar Pharmaceuticals (Subject)
Lee Howard (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
5:49 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
5:30 PM
Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
5:36 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
2:37 PM
Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2023
2:28 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2023
11:46 AM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2023
6:59 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
7:01 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
12:39 PM
Amphastar Pharmaceuticals (Subject)
ZASLOFF MICHAEL A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2023
10:22 AM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2023
6:17 AM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2023
7:07 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AMPH) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners